Merck's CEO Richard Clark has unveiled plans to enter the biotech drug market by creating Merck BioVentures (MBV), a global division focused on developing biotech drugs, in particular copycat ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback